Shining a light on brain cancer: new therapy aims to target tumors during surgery
NCT ID NCT05736406
Summary
This study is testing the safety of a new light-based treatment for an aggressive type of brain cancer called glioblastoma. The treatment, called photodynamic therapy (PDT), is given during surgery to remove the tumor and is followed by standard chemotherapy. The main goal is to find the safest and most effective dose of light to use with the special drug that makes cancer cells sensitive to it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU De Lille, Hôpital Roger Salengro
RECRUITINGLille, 59037, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
UPMC Hillman Cancer center
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.